272545 Aggregation of Data Used to Inform Comprehensive Cancer Planning and Implementation

Tuesday, October 30, 2012 : 8:45 AM - 9:00 AM

Thomas Tucker, PhD , Markey Cancer Center, Cancer Prevention and Control, University of Kentucky College of Public Health, Lexington, KY
Cancer epidemiology data available through state cancer registries is vital to comprehensive cancer control planning, implementation, and evaluation including assessment of the cancer burden, setting goals and objectives, guiding community priorities and intervention selection, and measuring program impact. This panel session will highlight the systematic process developed by the Kentucky Cancer Registry and Kentucky Cancer Consortium for aggregating cancer epidemiology and sociodemographic data, presenting this data to state and community constituents for intervention planning and evaluation, and how this process influenced colorectal cancer screening, incidence, and mortality rates in Kentucky. This process can be adopted by other state and community organizations to translate cancer epidemiology data into public health practice to reduce the burden of disease. The purpose of this specific presentation is to provide educators, clinicians and public health practitioners with an understanding of the process used to aggregate different data sources, including cancer incidence and mortality, cancer staging, cancer screening, and socio-demographics, to inform local cancer control planning and implementation.

Learning Areas:
Administration, management, leadership
Chronic disease management and prevention
Public health or related research

Learning Objectives:
Attendees will be able to describe how cancer epidemiology and sociodemographic data is aggregated for use in comprehensive cancer control planning at state and local levels.

Keywords: Cancer, Epidemiology

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Associate Director for Cancer Prevention and Control at the Markey Cancer Center and an Associate Professor in the UK College of Public Health. I am the Director of the Kentucky Cancer Registry. I am the Principal Investigator for the National Cancer Institute (NCI), Surveillance Epidemiology and End Results (SEER) program in Kentucky; and the Principal Investigator for the Centers for Disease Control and Prevention (CDC), National Program of Cancer Registries in Kentucky.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.